GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow GEHC
GE HealthCare Technologies Inc. (GEHC) Revenue growth
GE HealthCare Technologies Inc.'s revenue growth over the twelve months to 30 June 2026 was 6.51%, up 1.7 percentage points from fiscal 2025 (4.84%). Over the past ten years it has ranged from 0.61% (fiscal 2024) to 6.60% (fiscal 2023); the current reading is higher than 83% of that period. That is below the Medical Devices industry median of 8.80% and below the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 4.84% | 4.23 |
| FY2024 | 0.61% | (5.99) |
| FY2023 | 6.60% | 2.30 |
| FY2022 | 4.30% | 1.85 |
| FY2021 | 2.45% | (0.74) |
| FY2020 | 3.19% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 5.75% | (1.66) |
| Mar 2026 | 7.41% | 0.30 |
| Dec 2025 | 7.11% | 1.35 |
| Sep 2025 | 5.76% | 2.29 |
| 10 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PEN Penumbra, Inc. compare | 17.6% |
| DXCM DexCom, Inc. compare | 15.5% |
| EW Edwards Lifesciences Corporation compare | 14.6% |
| BSX Boston Scientific Corporation compare | 13.5% |
| PHG Koninklijke Philips N.V. compare | 9.11% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 8.62% |
| STE STERIS plc compare | 8.37% |
| GEHC GE HealthCare Technologies Inc. | 6.51% |
| SNN Smith & Nephew SNATS, Inc. compare | 4.81% |
| Medical Devices industry median | 8.80% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on GEHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement